JP2022514734A5 - - Google Patents
Info
- Publication number
- JP2022514734A5 JP2022514734A5 JP2021533155A JP2021533155A JP2022514734A5 JP 2022514734 A5 JP2022514734 A5 JP 2022514734A5 JP 2021533155 A JP2021533155 A JP 2021533155A JP 2021533155 A JP2021533155 A JP 2021533155A JP 2022514734 A5 JP2022514734 A5 JP 2022514734A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- cdr
- pharmaceutical composition
- antibody
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025086417A JP2025128164A (ja) | 2018-12-11 | 2025-05-23 | 抗ｔｒｅｍ２抗体の使用方法 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| USPCT/US2018/065026 | 2018-12-11 | ||
| PCT/US2018/065026 WO2019118513A1 (en) | 2017-12-12 | 2018-12-11 | Anti-trem2 antibodies and related methods |
| US201962889990P | 2019-08-21 | 2019-08-21 | |
| US62/889,990 | 2019-08-21 | ||
| PCT/US2019/065743 WO2020123664A1 (en) | 2018-12-11 | 2019-12-11 | Methods of using anti-trem2 antibodies |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025086417A Division JP2025128164A (ja) | 2018-12-11 | 2025-05-23 | 抗ｔｒｅｍ２抗体の使用方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022514734A JP2022514734A (ja) | 2022-02-15 |
| JP2022514734A5 true JP2022514734A5 (enExample) | 2022-12-15 |
| JP7688579B2 JP7688579B2 (ja) | 2025-06-04 |
Family
ID=71076653
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021533155A Active JP7688579B2 (ja) | 2018-12-11 | 2019-12-11 | 抗ｔｒｅｍ２抗体の使用方法 |
| JP2025086417A Pending JP2025128164A (ja) | 2018-12-11 | 2025-05-23 | 抗ｔｒｅｍ２抗体の使用方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025086417A Pending JP2025128164A (ja) | 2018-12-11 | 2025-05-23 | 抗ｔｒｅｍ２抗体の使用方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20210317211A1 (enExample) |
| EP (1) | EP3893931A4 (enExample) |
| JP (2) | JP7688579B2 (enExample) |
| KR (1) | KR20210104079A (enExample) |
| CN (1) | CN113194994B (enExample) |
| AU (1) | AU2019397479A1 (enExample) |
| CA (1) | CA3120875A1 (enExample) |
| WO (1) | WO2020123664A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2961950A1 (en) | 2014-09-28 | 2016-03-31 | The Regents Of The University Of California | Modulation of stimulatory and non-stimulatory myeloid cells |
| AU2018383709B2 (en) | 2017-12-12 | 2025-09-11 | Pionyr Immunotherapeutics, Inc. | Anti-TREM2 antibodies and related methods |
| BR112021015656A2 (pt) | 2019-02-20 | 2021-10-05 | Denali Therapeutics Inc. | Anticorpos anti-trem2 e métodos de uso dos mesmos |
| JP2023512450A (ja) | 2020-01-13 | 2023-03-27 | デナリ セラピューティクス インコーポレイテッド | 抗ｔｒｅｍ２抗体及びその使用方法 |
| IL285416A (en) * | 2021-08-05 | 2023-03-01 | Yeda Res & Dev | Antibodies for cancer treatment |
| CN113929785B (zh) * | 2021-09-10 | 2023-05-23 | 钦元再生医学(珠海)有限公司 | 一种可自分泌pd1-trem2双特异性抗体的嵌合抗原受体免疫细胞及其应用 |
| WO2024250809A1 (zh) * | 2023-06-08 | 2024-12-12 | 成都优洛生物科技有限公司 | 抗trem2全人源抗体或其抗原结合片段及其应用 |
| WO2025046298A2 (en) | 2023-09-01 | 2025-03-06 | iTeos Belgium SA | Anti-trem2 antibodies and methods of use |
| CN119735683B (zh) * | 2023-12-21 | 2025-10-31 | 华润生物医药有限公司 | 抗trem2抗体及其用途 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201311487D0 (en) * | 2013-06-27 | 2013-08-14 | Alligator Bioscience Ab | Bispecific molecules |
| CA2955086A1 (en) | 2014-08-08 | 2016-02-11 | Alector Llc | Anti-trem2 antibodies and methods of use thereof |
| CA2961950A1 (en) | 2014-09-28 | 2016-03-31 | The Regents Of The University Of California | Modulation of stimulatory and non-stimulatory myeloid cells |
| WO2017058866A1 (en) | 2015-09-28 | 2017-04-06 | Precision Immune, Inc. | Anti-trem2 antibodies and uses thereof |
| US20190330335A1 (en) * | 2015-10-06 | 2019-10-31 | Alector Llc | Anti-trem2 antibodies and methods of use thereof |
| MX2018013038A (es) * | 2016-04-27 | 2019-03-28 | Pfizer | Anticuerpos anti-il-33, composiciones, metodos y usos de los mismos. |
| AU2018383709B2 (en) * | 2017-12-12 | 2025-09-11 | Pionyr Immunotherapeutics, Inc. | Anti-TREM2 antibodies and related methods |
-
2019
- 2019-12-11 KR KR1020217021577A patent/KR20210104079A/ko not_active Ceased
- 2019-12-11 EP EP19895894.4A patent/EP3893931A4/en not_active Withdrawn
- 2019-12-11 CA CA3120875A patent/CA3120875A1/en active Pending
- 2019-12-11 CN CN201980081883.4A patent/CN113194994B/zh active Active
- 2019-12-11 WO PCT/US2019/065743 patent/WO2020123664A1/en not_active Ceased
- 2019-12-11 JP JP2021533155A patent/JP7688579B2/ja active Active
- 2019-12-11 AU AU2019397479A patent/AU2019397479A1/en active Pending
-
2021
- 2021-06-10 US US17/344,839 patent/US20210317211A1/en active Pending
-
2025
- 2025-05-23 JP JP2025086417A patent/JP2025128164A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022514734A5 (enExample) | ||
| JP2021506244A5 (enExample) | ||
| JP7438939B2 (ja) | Ｃｄ１３７を標的とする抗体とその利用方法 | |
| KR102522693B1 (ko) | 세포독성 t-림프구-관련 단백질 4 (ctla-4)에 대한 신규의 단일클론 항체 | |
| JP2021531005A5 (enExample) | ||
| EP3470426A1 (en) | Multispecific antibody | |
| AU2018348429A1 (en) | Multispecific antibody | |
| ME02093B (me) | Antitijela za humani receptor programirane smrti pd-1 | |
| JP2021514973A5 (enExample) | ||
| CN108136001A (zh) | 使用TGF-β抑制剂和PD-1抑制剂治疗癌症 | |
| TW202222835A (zh) | 抗ＳＩＲＰα抗體及其用途 | |
| JP2023549555A5 (enExample) | ||
| AU2017379382A1 (en) | Anti-CD3 Antibody and Molecules Comprising the Antibody | |
| CN111808190B (zh) | 结合pd-1的抗体 | |
| JP2022533538A5 (enExample) | ||
| AU2017358359B2 (en) | Antibody binding specifically to CD66c and use thereof | |
| KR20180118220A (ko) | Gitr 항체, 방법, 및 용도 | |
| AU2022358522A1 (en) | B7-h4 antibody-drug conjugates for the treatment of cancer | |
| KR20200063147A (ko) | Pdl1 표적화 항체 및 이의 사용 방법 | |
| CN111712521A (zh) | Cd38蛋白抗体及其应用 | |
| WO2023040940A1 (zh) | Pvrig/tigit结合蛋白联合免疫检查点抑制剂用于治疗癌症 | |
| JP2025511288A (ja) | 抗ｐｖｒｉｇ抗体、その医薬組成物及びその使用 | |
| CN115210261A (zh) | 抗半乳糖凝集素-9抗体及其用途 | |
| CN119095873A (zh) | 用于靶向杀伤GPC3阳性恶性细胞的双特异性GPC3xCD28和GPC3xCD3抗体及其组合 | |
| JP2022523145A5 (enExample) |